The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Find out more about our and our members' work around the world.
Innovations in Circulatory Care and Technologies
Home > Global Summit on Circulatory Health > 4th Global Summit on Circulatory Health
The 4th Global Summit on Circulatory Health will be held in Paris, France on 29-30 August 2019 under the theme Innovations in Circulatory Care and Technologies.
Exploring technological innovations and its implications for circulatory diseases has never been timelier. The 4th Summit Global Summit on Circulatory Health aims to create a space where clinicians, policymakers, researchers, advocates from civil society and private sector representatives can network and debate critical issues of circulatory health in a wider global health context. It will examine how digital health platforms, mHealth, and artificial intelligence are impacting health systems and drugs discovery, challenging regulatory systems and re-shaping the nexus between health, technology, and the law. Whether you are a clinician, a policymaker, a health advocate or a researcher, technological health innovations may already be influencing the way you work, interact with your patients, develop policies or interpret research results.
The Summit will bring together an impressive group of thought leaders and practitioners to explore together — through keynote lectures, panels and workshops — how to create an environment where innovations can be leveraged for better circulatory care and for more cost-effective and accessible health systems.
Welcome & Introduction
The role of digital health in medicine
Artificial intelligence is coming and it will help the cardiovascular space
Panel discussion: Harnessing mobile and online technologies for better health
Innovations in drug discovery
Implications of AI & digital health across different income settings
Panel discussion: Understanding the regulatory impact of artificial intelligence
Implications of digital health for health systems
Bringing health innovations to market
Highlights from the previous day
Better Hearts Better Cities
The future of digital health in the European Union
Panel discussion: How do we move forward on AI and digital solutions in circulatory health?
Closing remarks and Calls to Action
Ann Aerts has been Head of the Novartis Foundation since January 2013, where she has played a key role in devising new policy recommendations. She has the exciting responsibility of heading an organization committed to exploring innovative solutions to public health problems. The Novartis Foundation has the challenging goals of expanding access to quality healthcare and eliminating diseases such as leprosy and malaria. Before her current role, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism in Novartis Pharma Belgium. Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva and was Health Coordinator for the ICRC in several countries. Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, as well as a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. In 2014, Ann was nominated by PharmaVOICE as one of the 100 Most Inspiring People in the life science industry.
Liz Ashall-Payne is passionate about the opportunities that technology and particularly apps offer to improve health and care efficiencies and outcomes. Liz founded ORCHA, the Organisation for the Review of Care and Health Application in 2015, determined to present a way to offer much needed guidance to app developers to help raise app quality, as well as helping the public and professionals to confidently find and apply apps that could genuinely improve public, patient and organisational outcomes.
Jeroen Bax, ESC Immediate Past-President (2018-2020) is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals.
Shreya Bhatt is Medic Mobile’s Asia Regional Director. She leads the organization’s digital health programs, partnerships and team across several countries in the Asia region including India, Nepal and Indonesia. She is passionate about development and the potential for technology and innovation to accelerate progress towards universal health coverage. Previously, Shreya worked with organizations such as UNICEF, Teach for India, and Trickle Up to support development programs in education, livelihoods, and socioeconomic empowerment. Shreya transitioned to a career in international development from the private sector, having worked in corporate finance for several years. Shreya holds a BSc in Finance and Management from New York University, and a Master of International Affairs in Economic and Political Development from Columbia University.
Eugene Boadu has more than a decade’s experience working across academia, entrepreneurship, corporate intrapreneurship, and at the interfaces of private enterprise and public administration. He is currently a leader in the operations design and strategy formulation groups in mPedigree Network, a social enterprise building and deploying many innovative technologies for human security, trade standards, and market exchange facilitation, with particular emphasis on anti-counterfeiting, supply chain transformation, predictive analytics, infra-sensors, and brand equity. Trained in Economics and Political Science at the University of Ghana, Legon, Boadu is a prolific speaker and trainer, and has headlined multiple global and regional conferences and workshops on four continents, including the Global Entrepreneurship Summit under the auspices of President Barack Obama and The 2016 Ashoka Changemaker Summit.
Nancy Brown is Chief Executive Officer of the American Heart Association (AHA). The Association is a relentless force for a world of longer, healthier lives dedicated to ensuring equitable health for all – in the U.S. and around the world. Serving as CEO since 2008, Nancy has elevated the AHA as a global leader in heart disease and stroke science innovation. Under her leadership and 30+ year AHA career, the Association established the first-ever definition of “cardiovascular health” and just announced its bold 2030 global aspiration: “Together with global and local collaborators, we will equitably increase worldwide healthy life expectancy from 64 to at least 67, by 2030.”
Ben Freedman is Deputy Director Cardiovascular Strategy at Sydney’s Heart Research Institute and Charles Perkins Centre. He is Professor of Cardiology at the University of Sydney and former head of Department of Cardiology Concord Hospital. He is also Adjunct Professor in the School of Public Health & Preventive Medicine at Monash University, Honorary Professorial Fellow at the University of Melbourne and Visiting Professor and Lui Che Woo Distinguished Professor at the Chinese University of Hong Kong. He was Deputy Dean of Sydney Medical School for 9 years from 2003-12, and received the Faculty’s inaugural Distinguished Service Award in 2012. His major research interest focus is stroke prevention in atrial fibrillation, and in particular the role of screening for AF. In 2015 he formed the AF-SCREEN International Collaboration which now has 160 members from 36 countries, including many of the foremost names in AF research, and recently produced an important white paper on screening for AF which he led. He has authored over 220 publications, with over 7,500 citations . In 2002 he was scientific chairman of the successful World Congress of Cardiology. In 2011 he was awarded the Order of Australia Medal for service to medicine as a clinician, educator and researcher.
Dipak Kalra, PhD, FRCGP, FBCS, is President of the European Institute for Innovation through Health Data and of the European Institute for Health Records. He plays a leading international role in research and development of electronic health record architectures and systems. He has led multiple European projects in these areas, including Horizon 2020 and the IMI programme alongside pharma companies, hospitals and ICT companies. He recently co-led a €16m project on the re-use of EHR information for clinical research, EHR4CR, alongside ten global pharma. He is a partner in another IMI project, EMIF, on the development of a European clinical research platform federating multiple population health and cohort studies. Dipak is Clinical Professor of Health Informatics at University College London, Visiting Professor at the University of Gent, a member of the openEHR Foundation, and standards bodies including CEN, ISO and HL7.
Carolyn Lam is a Senior Consultant of the National Heart Centre, Singapore; Professor of Duke-NUS Cardiovascular Academic Clinical Program; Director of the Clinical & Translational Research Office at NHCS; Scientific Advisor to the Clinical Trials Coordinating Centre at SingHealth and Affiliate Member of the SingHealth Duke-NUS Institute of Precision Medicine. She graduated from the Faculty of Medicine, National University of Singapore, completed advanced specialty training in Cardiology in Singapore, and pursued her Research Fellowship at the Cardiorenal Laboratory, Heart Failure Fellowship at the Division of Cardiovascular Diseases, and Advanced Cardiology and Master of Biomedical Sciences at Mayo Clinic, Rochester MN. She received further training in clinical and genetic epidemiology at the Framingham Heart Study in Boston, MA, graduated from the Stanford Executive Programme and obtained her PhD at University Medical Centre Groningen. Dr Lam is heard weekly on the global podcast “Circulation On The Run” and seen regularly on television as the Resident Doctor of the health programme “Body and Soul” by MediaCorp Singapore.
Riccardo Lampariello is the Head of Health Programme at Terre des hommes, the Swiss leading child relief agency improving the lives of millions of children around the world, where he is responsible to increase the organization impact in two main areas: Maternal, Child and Newborn Health and Cardiac Pediatric Surgery. In collaboration with the innovation unit, he drives the uptake on innovative projects – disruptive and incremental- in the organization’s activities. Riccardo has 20 years professional experience, mainly in Global Public Health and Pharma, and holds a Master of Business Administration (MBA) and Master of Science (MSc) in Applied Statistics.
Erica Layer is the CEO of D-tree International, a digital health organization working at the intersection of health and technology to support integration of technology into health systems in low and middle-income countries which result in improved access and quality of healthcare. D-tree has been a pioneer in the field of global digital health for 15 years and are supporting governments in Zanzibar and Malawi to create national digital health systems, as well as working with NGO partners on projects in 16 countries. Ms. Layer brings over 12 years of experience working with health and technology, having lived in Tanzania for the past 8 years. She has a master’s in international health from Johns Hopkins University and a Bachelor’s in Chemistry from the College of Saint Benedict.
Francisco Lopez-Jimenez is a Professor of Medicine at Mayo College of Medicine, the chair of the Division of Preventive Cardiology, the Director of Research at the Dan Abraham Healthy Living Center, and the Co-Director of Artificial Intelligence in Cardiology at Mayo Clinic. He is also the Chair of the International Committee for the American Association of Cardiovascular and Pulmonary Rehabilitation. He has published more than 200 scientific publications, including invited editorials in journals like Lancet, and his scientific work has been cited more than 4,000 times. He is a member of the editorial boards of the American Journal of Cardiology, the European Journal of Preventive Cardiology, Archives of Cardiology and the Journal of Clinical Investigation. He has been frequently featured by the national media, including the New York Times, the Wall Street Journal, CNN and NBC, and has been a guest speaker at National Public Radio on topics related to preventive cardiology.
Valerie Luyckx obtained her MD degree (MBBCh) from the University of the Witwatersrand in South Africa and an MSc in Public Health in Developing Countries from the London School of Hygiene and Tropical Medicine. She completed her residency in internal medicine at Jackson Memorial Hospital, University of Miami, and nephrology training at the Brigham and Women’s and Massachusetts General Hospitals, Harvard University. She has held clinical faculty positions at the University of the Witwatersrand, Harvard University and the University of Alberta in Edmonton Canada as Associate Professor. She is an associate lecturer in the Renal Division at the Brigham, and Women’s Hospital, Harvard University. Her clinical experience includes practice of Nephrology and Internal Medicine across a broad range of health systems, including South Africa, Malawi, Haiti, USA, urban and remote Canada and Switzerland. She is currently engaged in research in Biomedical Ethics at the University of Zurich and as a consultant for the World Health Organization working on projects relating to ethics in Health Policy and Systems Research, public health ethics and ethical challenges of non-communicable diseases.
Calum MacRae, MD, PhD, is the Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital in Boston, an Associate Professor of Medicine at Harvard Medical School, a Principal Faculty Member at the Harvard Stem Cell Institute, and an Associate Member at the Broad Institute of Harvard and MIT. Calum works on the human genetics of cardiac and vascular disease, cardiovascular developmental biology, and drug discovery. His major clinical focus is the Cardiovascular Clinical Genetics Center, he co-directs the Genomic Medicine Program and has established a Next Gen Phenotyping Center at Brigham and Women’s Hospital.
Robert Madelin is the Chairman of Fipra International Ltd, a global public affairs advisory firm with boots on the ground in 50 countries around the world, including Canada and every EU member state. Robert also holds a Visiting Research Fellowship at the Centre for Technology and Global Affairs of the University of Oxford. Before joining Fipra in 2016, Robert served as a public servant during 4 decades in both the UK and the European Union. He has notably led the European Commission’s telecommunications policy and regulatory arm, ‘DG CONNECT’, as Director General, 2010-15. Robert is the author of ‘Opportunity Now: Europe’s mission to innovate’ (2016) and a co-author of ‘An ethical framework for a good AI society’ (2018). Robert is Honorary Fellow of the Royal College of Physicians of London, and Honorary Doctor of the University of Edinburgh.
Christoph Nabholz, Head Life & Behaviour R&D and Managing Director, Swiss Re. Christoph’s team provides applied R&D aimed at improving the understanding of insurance industry trends and developments in consumer behaviour, morbidity and mortality. Insights are applied to strengthen the steering, performance and innovation of Swiss Re’s Life & Health book and provide added value services to our clients. His team’s research and collaborations with leading research institutions and insurance corporates, allow them to develop forward-looking views on key portfolio drivers. Christoph started at Swiss Re in 2002 and held several positions in Swiss Re Global Life & Health Underwriting, Centre for Global Dialogue and Group Underwriting.
Sukhbinder Noorpuri is a multiple prize-winning doctor with nearly 2 decades of NHS experience who has founded the i-GP service and overseen its growth from inception to national roll out across the UK. Utilising branching logic based on national guidelines architected within image enhanced proprietary software, the i-GP Platform is a world first in design and has a patient satisfaction rate of 99.75% from thousands treated. Regarded as a visionary in the field of digital health, he is CEO Today’s Healthcare Award winner 2018, the TiE Chairman’s Award Winner 2018 and Gamechanger of the Year 2018. In all, i-GP has won over 20 industry awards inside 3 years of service. Dr Noorpuri is currently working with the NHS to bring the unique Platform to the UK population with a validated health economic benefit of £4 billion.
Karen Sliwa is President of the World Heart Federation and a Professor at the Hatter Institute for Cardiovascular Research in Africa (HICRA) at the University of Cape Town. Born in Germany, she is a clinician-scientist, having trained in Germany, Scotland and Israel. In 1992, Karen immigrated to South Africa where she completed her clinical training as a specialist physician, cardiologist and obtained a Diploma in Tropical Medicine and Hygiene. In 2002 she was awarded a PhD from the University of the Witwatersrand and she contributed to > 250 peer-reviewed articles and trained > 30 postgraduate students so far. Professor Sliwa is highly experienced in developing, designing and leading cardiovascular disease (CVD) studies in various healthcare environments in Africa. She devised innovative strategies to raise funds through numerous sources at a time when very limited funding was available for non-communicable disease (NCD) research.
Ruth Webster is the Global Head of Medicine in George Health Technologies, a social enterprise of The George Institute for Global Health. George Health Technologies aims to scaleup effective digital health solutions to improve the diagnosis and management of chronic disease globally. Dr Webster is also the Head of Technical Transfer within The George Institute for Global Health with responsibility for ensuring smooth transfer of intellectual property generated by The George Institute’s world leading researchers into the social enterprise arm for scaleup. As a researcher, she has a particular interest in the development of novel strategies to bridge the evidence-practice gap in Cardiovascular Disease prevention.
Heart disease and stroke remain the world’s foremost causes of premature death, despite being largely preventable through the mitigation of risk factors. Together, the cardiovascular disease (CVD) community and multi-sectoral partners need to reframe outreach strategies and tools for action to raise the priority status of CVD nationally and globally.
The Global Summit on Circulatory Health is the thought leadership event designed to elevate the world’s number one killer as the top priority for Key Opinion Leaders, Ministers of Health and Public Health Officials, and Industry Leaders.
The aim of the Summit is to:
Hear from previous attendees on why you should attend the Global Summit on Circulatory Health: